Form 4 for INMB Inmune Bio, Inc.
Accepted 2022-05-31 00:00:00 ET · period of report 2022-05-26 · accession 0001213900-22-030208 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-05-31 | 2022-05-26+ | INMB | Moss David J | CFO, Treas, Sec, 10% | P - Purchase | $6.42 | +10.7K | 1.25M | +0.9% | +$68.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-26 | P | A | 7,700 | $6.27 | 1,244,651 | D | — | — | (F1) Represents the average purchase price at a range of between $6.11 and $6.29 per share. |
| 2 | Common | Common Stock | 2022-05-27 | P | A | 3,000 | $6.79 | 1,247,651 | D | — | — | (F2) Represents the average purchase price at a range of between $6.77 and $6.79 per share. |